AtaiBeckley (ATAI) Shares Outstanding (Diluted Average) (2021 - 2026)

AtaiBeckley (ATAI) recorded quarterly Shares Outstanding (Diluted Average) of $357.4 million in Q1 2026, up 57.78% quarter-over-quarter from $226.5 million in Q4 2025, and up 102.77% on a YoY basis from $176.3 million in Q1 2025.

AtaiBeckley (ATAI) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends

AtaiBeckley's Shares Outstanding (Diluted Average) history runs 3 years deep, the most recent figure standing at $357.4 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 102.77% year-over-year to $357.4 million; the TTM figure through Mar 2026 stood at $357.4 million (up 102.77% YoY), while the FY2025 annual figure was $226.5 million, up 41.44% from the prior year.
  • Shares Outstanding (Diluted Average) was $357.4 million for Q1 2026 at AtaiBeckley, up from $226.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $217.6 million in Q3 2025 to a low of $121.4 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $155.8 million (2023), against an average of $158.6 million.
  • The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Diluted Average) surged 41.44% in 2025, then surged 102.77% in 2026.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $160.2 million in 2024, then surged by 41.44% to $226.5 million in 2025, then soared by 57.78% to $357.4 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $357.4 million (Q1 2026), $226.5 million (Q4 2025), and $176.3 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 AtaiBeckley 1.45 Bn 1.45 Bn - 357.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 357.42 Mn
Dec 31, 2025 226.53 Mn
Sep 30, 2025 217.60 Mn
Jun 30, 2025 196.56 Mn
Mar 31, 2025 176.27 Mn
Mar 31, 2025 176.27 Mn
Dec 31, 2024 160.16 Mn
Mar 31, 2024 158.89 Mn
Dec 31, 2023 158.83 Mn
Sep 30, 2023 177.57 Mn
Jun 30, 2023 155.79 Mn
Mar 31, 2023 155.79 Mn
Dec 31, 2022 155.72 Mn
Sep 30, 2022 156.61 Mn
Jun 30, 2022 153.97 Mn
Mar 31, 2022 153.53 Mn
Dec 31, 2021 138.27 Mn
Sep 30, 2021 134.33 Mn
Jun 30, 2021 125.80 Mn
Mar 31, 2021 121.37 Mn